{"id":"https://openalex.org/W2808653175","doi":"https://doi.org/10.1158/1078-0432.ccr-17-3761","title":"Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia","display_name":"Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia","publication_year":2018,"publication_date":"2018-06-12","ids":{"openalex":"https://openalex.org/W2808653175","doi":"https://doi.org/10.1158/1078-0432.ccr-17-3761","mag":"2808653175","pmid":"https://pubmed.ncbi.nlm.nih.gov/29895707"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-17-3761","doi":"https://doi.org/10.1158/1078-0432.ccr-17-3761","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-17-3761","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063755644","display_name":"Matthew Steven Davids","orcid":"https://orcid.org/0000-0003-4529-2003","observed_orcids":["https://orcid.org/0000-0003-4529-2003"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew S. Davids","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076077834","display_name":"Michael J. Hallek","orcid":"https://orcid.org/0000-0002-7425-4455","observed_orcids":["https://orcid.org/0000-0002-7425-4455"]},"institutions":[{"id":"https://openalex.org/I180923762","display_name":"University of Cologne","ror":"https://ror.org/00rcxh774","country_code":"DE","type":"education","lineage":["https://openalex.org/I180923762"]},{"id":"https://openalex.org/I4210138270","display_name":"Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases","ror":"https://ror.org/04c4bwh63","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210138270"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Hallek","raw_affiliation_strings":["2Department I of Internal Medicine, Center of Integrated Oncology K\u00f6ln Bonn (CIO K\u00f6ln Bonn), and Cluster of Excellence on Cellular Stress Responses in Aging (CECAD), University of Cologne, K\u00f6ln, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department I of Internal Medicine, Center of Integrated Oncology K\u00f6ln Bonn (CIO K\u00f6ln Bonn), and Cluster of Excellence on Cellular Stress Responses in Aging (CECAD), University of Cologne, K\u00f6ln, Germany","institution_ids":["https://openalex.org/I180923762","https://openalex.org/I4210138270"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Wierda","raw_affiliation_strings":["3University of Texas MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of Texas MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033407869","display_name":"Andrew Warwick Roberts","orcid":"https://orcid.org/0000-0002-7341-5720","observed_orcids":["https://orcid.org/0000-0002-7341-5720","https://orcid.org/0000-0001-5347-7169"]},"institutions":[{"id":"https://openalex.org/I1320473756","display_name":"The Royal Melbourne Hospital","ror":"https://ror.org/005bvs909","country_code":"AU","type":"funder","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]},{"id":"https://openalex.org/I196021976","display_name":"Walter and Eliza Hall Institute of Medical Research","ror":"https://ror.org/01b6kha49","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I196021976"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew W. Roberts","raw_affiliation_strings":["4Royal Melbourne Hospital, Peter MacCallum Cancer Centre, and Walter and Eliza Hall Institute of Medical Research, Cancer and Hematology Division, Melbourne, Australia"],"raw_orcid":"https://orcid.org/0000-0002-7341-5720","affiliations":[{"raw_affiliation_string":"4Royal Melbourne Hospital, Peter MacCallum Cancer Centre, and Walter and Eliza Hall Institute of Medical Research, Cancer and Hematology Division, Melbourne, Australia","institution_ids":["https://openalex.org/I1320473756","https://openalex.org/I196021976","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019866348","display_name":"Stephan Stilgenbauer","orcid":"https://orcid.org/0000-0002-6830-9296","observed_orcids":["https://orcid.org/0000-0002-6830-9296"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephan Stilgenbauer","raw_affiliation_strings":["5Internal Medicine III, Ulm University, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Internal Medicine III, Ulm University, Ulm, Germany","institution_ids":["https://openalex.org/I196349391"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102896676","display_name":"Jeffrey Alan Jones","orcid":"https://orcid.org/0000-0001-9557-0820","observed_orcids":["https://orcid.org/0000-0001-9557-0820"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Jones","raw_affiliation_strings":["6The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069721801","display_name":"John F. Gerecitano","orcid":"https://orcid.org/0009-0001-0501-5688","observed_orcids":["https://orcid.org/0009-0001-0501-5688","https://orcid.org/0000-0002-9300-9287"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John F. Gerecitano","raw_affiliation_strings":["7Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100645032","display_name":"Su Young Kim","orcid":"https://orcid.org/0000-0002-6486-8445","observed_orcids":["https://orcid.org/0000-0002-6486-8445","https://orcid.org/0000-0001-7190-0362"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Su Young Kim","raw_affiliation_strings":["8AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091254943","display_name":"Jalaja Potluri","orcid":"https://orcid.org/0000-0002-1146-8253","observed_orcids":["https://orcid.org/0000-0002-1146-8253"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jalaja Potluri","raw_affiliation_strings":["8AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112254057","display_name":"Todd A. Busman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd Busman","raw_affiliation_strings":["8AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066903086","display_name":"Andrea Best","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Best","raw_affiliation_strings":["8AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113792916","display_name":"Maria E. Verdugo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria E. Verdugo","raw_affiliation_strings":["8AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001205753","display_name":"Elisa Cerri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisa Cerri","raw_affiliation_strings":["8AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013603805","display_name":"Monali Bhardwaj Desai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monali Desai","raw_affiliation_strings":["8AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047631289","display_name":"Peter Hillmen","orcid":"https://orcid.org/0000-0001-5617-4403","observed_orcids":["https://orcid.org/0000-0001-5617-4403"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter Hillmen","raw_affiliation_strings":["9University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081326206","display_name":"John Francis Seymour","orcid":"https://orcid.org/0000-0003-2188-6835","observed_orcids":["https://orcid.org/0000-0003-2188-6835"]},"institutions":[{"id":"https://openalex.org/I1320473756","display_name":"The Royal Melbourne Hospital","ror":"https://ror.org/005bvs909","country_code":"AU","type":"funder","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John F. Seymour","raw_affiliation_strings":["10Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia","institution_ids":["https://openalex.org/I1320473756","https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5063755644"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":13.1481,"has_fulltext":false,"cited_by_count":164,"citation_normalized_percentile":{"value":0.99363366,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"24","issue":"18","first_page":"4371","last_page":"4379"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9990000128746033},{"id":"https://openalex.org/keywords/relapsed-refractory-chronic-lymphocytic-leukemia","display_name":"relapsed/refractory chronic lymphocytic leukemia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.9459999799728394},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.734000027179718},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9169999957084656},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8289999961853027},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.949999988079071},{"id":"https://openalex.org/keywords/tumor-lysis-syndrome","display_name":"tumor lysis syndrome","score":0.7089999914169312},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.7620000243186951},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.8100000023841858},{"id":"https://openalex.org/keywords/idelalisib","display_name":"idelalisib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/growth-factor-support","display_name":"growth factor support","score":0.6370000243186951},{"id":"https://openalex.org/keywords/severe-infection","display_name":"serious infections","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9810758829116821},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.841949462890625},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6169993877410889},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6080732345581055},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5272183418273926},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5250142216682434},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4683883488178253},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.44024762511253357},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32720375061035156},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3206014931201935},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16063007712364197},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002872","descriptor_name":"Chromosome Deletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002886","descriptor_name":"Chromosomes, Human, Pair 17","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D041981","descriptor_name":"Gastrointestinal Tract","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D041981","descriptor_name":"Gastrointestinal Tract","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D058496","descriptor_name":"Smith-Magenis Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D058496","descriptor_name":"Smith-Magenis Syndrome","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058496","descriptor_name":"Smith-Magenis Syndrome","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-17-3761","doi":"https://doi.org/10.1158/1078-0432.ccr-17-3761","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-17-3761","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:29895707","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29895707","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:USBKOELN.ub.uni-koeln.de:17286","doi":null,"is_oa":false,"landing_page_url":"https://kups.ub.uni-koeln.de/17286/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400371","display_name":"K\u00f6lner Universit\u00e4ts PublikationsServer (Universit\u00e4t zu K\u00f6ln)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210115942","host_organization_name":"Rhenish Institute for Environmental Research","host_organization_lineage":["https://openalex.org/I4210115942"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"doc-type:article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8500000238418579}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1970329726","https://openalex.org/W2039640090","https://openalex.org/W2110525250","https://openalex.org/W2113278680","https://openalex.org/W2120388840","https://openalex.org/W2122479144","https://openalex.org/W2142099365","https://openalex.org/W2172242534","https://openalex.org/W2192121806","https://openalex.org/W2204827588","https://openalex.org/W2338693134","https://openalex.org/W2369297677","https://openalex.org/W2387451078","https://openalex.org/W2409945629","https://openalex.org/W2558511185","https://openalex.org/W2573476619","https://openalex.org/W2582696216","https://openalex.org/W2602605464","https://openalex.org/W2751217756","https://openalex.org/W2769920501","https://openalex.org/W2773047201","https://openalex.org/W2781558580","https://openalex.org/W2800186514","https://openalex.org/W2904446924","https://openalex.org/W4233562659"],"related_works":["https://openalex.org/W2761324813","https://openalex.org/W2590814247","https://openalex.org/W2979958839","https://openalex.org/W2519612839","https://openalex.org/W2986866283","https://openalex.org/W2762535272","https://openalex.org/W2764322962","https://openalex.org/W3030076241","https://openalex.org/W3214703271","https://openalex.org/W2806285688"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"The":[2,138],"oral":[3],"BCL-2":[4],"inhibitor":[5],"venetoclax":[6,55,103,213],"is":[7,241],"an":[8,63],"effective":[9],"therapy":[10,240],"for":[11],"patients":[12,59,174,205,211,246],"with":[13,22,60,191,223,247,252],"relapsed/refractory":[14],"(R/R)":[15],"chronic":[16],"lymphocytic":[17],"leukemia":[18],"(CLL),":[19],"including":[20],"disease":[21,34,232],"high-risk":[23],"genomic":[24],"features":[25],"such":[26],"as":[27,236],"chromosome":[28],"17p":[29],"deletion":[30],"[del(17p)]":[31],"or":[32,96],"progressive":[33],"following":[35],"B-cell":[36],"receptor":[37],"pathway":[38],"inhibitors.":[39],"Patients":[40,81],"and":[41,77,132,149,170,195,217],"Methods:":[42],"We":[43],"conducted":[44],"a":[45,84,180,237],"comprehensive":[46],"analysis":[47],"of":[48,51,86,100,118,160,172,183,200,210,226,231],"the":[49,109,112,153,158,198,224,229,253],"safety":[50],"400":[52,184],"mg":[53],"daily":[54,181],"monotherapy":[56],"in":[57,203,228,245],"350":[58],"CLL":[61,249],"using":[62],"integrated":[64],"dataset":[65],"from":[66],"three":[67,87],"phase":[68],"I/II":[69],"studies.":[70],"Results:":[71],"Median":[72,98],"age":[73],"was":[74,104,163,189,206],"66":[75],"years":[76],"60%":[78],"had":[79,82,167],"del(17p).":[80],"received":[83,94],"median":[85],"prior":[88],"therapies":[89],"(range:":[90],"0\u201315);":[91],"42%":[92],"previously":[93],"ibrutinib":[95],"idelalisib.":[97],"duration":[99],"exposure":[101],"to":[102,177,179,215],"16":[105],"months":[106],"(0\u201356).":[107],"In":[108],"pooled":[110],"analysis,":[111],"most":[113,139],"common":[114,140],"adverse":[115],"events":[116],"(AE)":[117],"any":[119],"grade":[120,141],"were":[121,144,175],"diarrhea":[122],"(41%),":[123],"neutropenia":[124,145,188],"(40%),":[125],"nausea":[126],"(39%),":[127],"anemia":[128,147],"(31%),":[129],"fatigue":[130],"(28%),":[131],"upper":[133],"respiratory":[134],"tract":[135],"infection":[136],"(25%).":[137],"3/4":[142,187],"AEs":[143,216],"(37%),":[146],"(17%),":[148],"thrombocytopenia":[150],"(14%).":[151],"With":[152],"current":[154,254],"5-week":[155],"ramp-up":[156,178],"dosing,":[157],"incidence":[159,199],"laboratory":[161],"TLS":[162],"1.4%":[164],"(2/166),":[165],"none":[166],"clinical":[168],"sequelae,":[169],"all":[171],"these":[173,204],"able":[176],"dose":[182,196],"mg.":[185],"Grade":[186],"manageable":[190],"growth":[192],"factor":[193],"support":[194],"adjustments;":[197],"serious":[201],"infections":[202],"15%.":[207],"Ten":[208],"percent":[209],"discontinued":[212],"due":[214],"8%":[218],"died":[219],"while":[220],"on":[221],"study,":[222],"majority":[225],"deaths":[227],"setting":[230],"progression.":[233],"Conclusions:":[234],"Venetoclax":[235],"long-term":[238],"continuous":[239],"generally":[242],"well":[243],"tolerated":[244],"R/R":[248],"when":[250],"initiated":[251],"treatment":[255],"algorithm.":[256],"Clin":[257],"Cancer":[258],"Res;":[259],"24(18);":[260],"4371\u20139.":[261],"\u00a92018":[262],"AACR.":[263]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":41},{"year":2020,"cited_by_count":22},{"year":2019,"cited_by_count":26},{"year":2018,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-21T00:00:00"}